Conference - San Diego, CA, USA
GTC is proud to announce its 2nd Immunogenicity and Immunotoxicity Conference, one of four parallel tracks to the Novel Immunotherapeutics Summit 2014 on January 29 - 31, 2014 in San Diego, CA.The conference will cover important progress made in the areas of therapeutic protein immunogenicity and immunotoxicity evaluation such as protein aggregation, clinical relevance and assessment of immunogenicity, mitigation of immunogenicity-related risks, biosimilar development, and immunotoxicity evaluation strategies.
The Immunogenicity and Immunotoxicity Conference will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.
Organization: Global Technology Community (GTC)
2nd Immunogenicity and Immunotoxicity Conference (Jan 29-31, 2014, San Diego, CA)
Jan 29, 2014 -Jan 31, 2014 (08:00-16:00)
Wyndham San Diego Bayside, San Diego, CA 92101, USA
Contact: Eileen Zhao (infogtcbio@gtcbio.com)
Phone number: 626-256-6405
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
